Leadership

Led by an entrepreneurial and experienced management team, supported by a distinguished Board

Executive team

Dr James McIlroy

MBChB, BMedSci (Hons)
CEO & BOARD MEMBER
Qualified medical doctor. Founded EnteroBiotix with the vision of building the world’s premier microbiome therapeutics company
Formed company, raised £47m, established technology platforms, initiated and completed clinical trials
Dr James Barnes

PhD
COO
Eighteen years’ strategic, leadership, drug development & business operations experience
Previously worked as COO at BerGenBio ASA, a listed oncology focussed biotech company. Prior to BerGenBio, worked at Vertex Pharmaceuticals (Europe) Ltd
Elmar Schnee

MA
EXECUTIVE CHAIRMAN
Previously CEO of Merck Serono
Currently serves as Chairman of the board of directors of Calliditas Therapeutics AG, ProCom Rx SA, Moleac Pte Ltd and Noorik Biopharmaceuticals AG as well as a member of the board of directors of Kuste Biopharma, Mindmaze SA and Damian Pharma AG
Kimberley McAleney

PGD
DIRECTOR OF PEOPLE & CULTURE
Extensive experience in the design and successful execution of HR strategy, supporting fast-paced scaling businesses across a variety of industries, including life sciences

Board of Directors

Felix Olale

Non-Executive Director
CEO at Medgenome North America and Europe. Sits as Chairman of MedGenome and Director of Ascent Meditech
Iain Baird

Investor Director
Principal, Development Solutions. >35 years of operational and leadership experience in the pharma industry
Mark Bamforth

Investor Director
Founder and CEO of ArrantaBio (acquired by Recipharm), Brammer Bio (acquired by Thermofisher)
Douglas Thomson

Investor Director
CEO and co-founder at Pneumagen Limited, a clinical phase anti-effective company
David Lawrence

Independent NXD
Previously CFO Valneva. Delivered 2021 NASDAQ IPO